Implantology and Sjögren*s syndrome: a multicenter prospective cohort study
- Conditions
- vervangen van ontbrekende kiezen of het ondersteunen van een gebitsprotheseDry mouth diseaseSjögren Syndrome10019190
- Registration Number
- NL-OMON44593
- Lead Sponsor
- Vrije Universiteit Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 120
Inclusion criteria (dentate group, Sjögren)
- The patient is at least 18 years and younger than 80;
- A diagnosed (by the AECG guidelines; see attachment) primary or secondary Syndrome of Sjögren;
- The missing or lost tooth/teeth are premolars and/or molars in the upper or lower jaw.
- Sufficient healthy and vital bone to insert a dental implant with a minimum length of 8 mm and at least 3.8 mm in diameter. In case of insufficient bone volume, a bone augmentation procedure will be performed with autologue bone mixed with artificial bone (tricalcium phosphate bone graft substitutes in combination with a membrane).
- The implant site must be free from infection;
- Adequate oral hygiene (modified plaque index and modified sulcus bleeding index * 1) (Mombelli et al., 1987; Loe and Silness, 1963)
- Sufficient mesio-distal, bucco-lingual, and interocclusal space for placement of an anatomic restoration;
- The patient is capable of understanding and giving informed consent.;Inclusion criteria (edentulous group, Sjögren)
- The patient is at least 18 years and younger than 80;
- A diagnosed (by the EULAR guidelines) primary or secondary Syndrome of Sjögren
- The patient is edentulous. Before final inclusion in the study the patient has to be edentulous for 1 year.
- Problems with conventional denture retention, stability and/or adaptation, which could be solved by an implant, supported denture.
- Sufficient healthy and vital bone to insert dental implants with a minimum length of 8 mm and at least 3.8 mm in diameter. In case of insufficient bone volume, a bone augmentation procedure and/or sinus elevation procedure will be performed with autologue bone mixed with artificial bone (tricalcium phosphate bone graft substitutes in combination with a membrane).
- The implant site must be free from infection;
- Capable of performing adequate oral hygiene;
- The patient is capable of understanding and giving informed consent.;Inclusion criteria control groups
- The inclusion criteria for the healthy control groups are similar as for the Sjögren groups without the Sjögren criterion.
Criteria used for excluding patients from this study are as follows:
- Medical and general contraindications for the surgical procedures;
- Presence of an active and uncontrolled periodontal disease as expressed by probing pockets depths > 4mm with bleeding upon probing;
- Smoking (patients who stop smoking six weeks before the operation can be included);
- A history of radiotherapy to the head and neck region.
- Use of intravenous bisphosphonates or the use of oral bisphosphonates for more than 5 years.
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Changes in marginal peri-implant bone loss of dental implants between the<br /><br>healthy and SS groups 1.5 years after finalization. </p><br>
- Secondary Outcome Measures
Name Time Method <p>Difference in clinical performance of dental implants between healthy and SS<br /><br>patients. Furthermore, a possible association between the outcome measures and<br /><br>Sjögren*s syndrome disease symptoms is studied*.<br /><br><br /><br>Clinical performance:<br /><br>- Implant survival.<br /><br>- Overdenture/crown survival.<br /><br>- Modified plaque-index and modified bleeding-index.<br /><br>- Probing depth.<br /><br>- Width of keratinized epithelium.<br /><br>- Patient satisfaction and impact of oral health on the quality of life.<br /><br><br /><br>*Sjogren*s syndrome disease symptoms (EULAR Sjögren*s Syndrome Patient Reported<br /><br>Index [ESSPRI]; SS groups only).</p><br>